Short-range intermittent claudication and rest pain: Microcirculatory effects of pentoxifylline in a randomized, controlled trial

Angiology

Volumn 53, Issue SUPPL. 1, 2002, Pages

  Incandela, L ^a   De Sanctis, M T ^a   Cesarone, M R ^a   Belcaro, G ^a   Nicolaides, A N ^a   Geroulakos, G ^a   Ramaswami, G ^a  

^a AP/PEA Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PENTOXIFYLLINE; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD CARBON DIOXIDE TENSION; BLOOD OXYGEN TENSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EXERCISE TOLERANCE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; LASER DOPPLER FLOWMETRY; MALE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN BLOOD FLOW; WALKING;

AGED; BLOOD PRESSURE; DOUBLE-BLIND METHOD; EXERCISE TEST; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MIDDLE AGED; PAIN; PENTOXIFYLLINE; REST; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VASODILATOR AGENTS; WALKING;

EID: 0036172725     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Efficiency of a new prostaglandin E regimen in outpatients with severe intermittent claudication: Results of a multicenter, placebo-controlled double-blind trial
2. Second European Consensus
3. Intermittent claudication: Be conservative
4. A review of the clinical effectiveness of exercise therapy for intermittent claudication
5. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels
6. Value of supervised exercise program for the therapy of arterial claudication
7. Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV
8. Changes of walking distance in patients with intermittent claudication during six months intensive physical training
9. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease
10. Planning clinical trials evaluating treatment in peripheral vascular disease due to atherosclerosis
11. Carotid plaque, intima-media thickness, cardiovascular risk factors and prevalent cardiovascular disease in men and women. The British Regional Heart study
12. Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disease
13. Oxpentifylline treatment of venous ulcers of the leg
14. Pentoxifylline: Effects on red cell deformability and oxygen availability from the blood in intermittent claudication